Sector focus
Capital for scientific progress and care delivery.
Biotechnology, diagnostics, medical technology, healthcare services, pharmaceutical platforms and healthcare infrastructure.
Market context
Why this sector matters.
Healthcare and life sciences are capital-intensive, regulated and deeply influenced by demographic, technological and policy trends. We support companies and investors navigating development, commercialisation, partnership and M&A across the sector.
Our focus spans biotechnology, diagnostics, medical devices, healthcare services, pharmaceutical platforms and healthcare infrastructure. Each stage brings distinct capital requirements, risk profiles and partnership needs.
Investment drivers
Structural forces shaping the opportunity.
- Aging populations and chronic disease burden
- Precision medicine and diagnostics innovation
- Medical technology and minimally invasive care
- Healthcare infrastructure and capacity expansion
- Regulatory and reimbursement pathways
Advisory
How we advise.
01
M&A and licensing strategy for biotech and pharma platforms
02
Financing for development and commercialisation
03
Partnership, joint venture and co-development structures
04
Healthcare services and technology consolidation
Investment
How we invest.
01
Biotechnology and pharmaceutical development platforms
02
Diagnostics and medical technology
03
Healthcare services and operating platforms
04